NCT02244320View on ClinicalTrials.gov

Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)

CompletedOBSERVATIONAL
Enrollment

4,150

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

May 31, 2003

Conditions
Prostatic Hyperplasia
Interventions
DRUG

Tamsulosin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY